Co-Authors
This is a "connection" page, showing publications co-authored by MIEN-CHIE HUNG and RIYAO YANG.
Connection Strength
3.311
-
Development and characterization of anti-galectin-9 antibodies that protect T cells from galectin-9-induced cell death. J Biol Chem. 2022 04; 298(4):101821.
Score: 0.852
-
Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy. Nat Commun. 2021 02 05; 12(1):832.
Score: 0.790
-
The role of T-cell immunoglobulin mucin-3 and its ligand galectin-9 in antitumor immunity and cancer immunotherapy. Sci China Life Sci. 2017 Oct; 60(10):1058-1064.
Score: 0.627
-
Inhibition of Galectin-9 sensitizes tumors to anthracycline treatment via inducing antitumor immunity. Int J Biol Sci. 2023; 19(14):4644-4656.
Score: 0.236
-
Phosphorylation and Stabilization of PD-L1 by CK2 Suppresses Dendritic Cell Function. Cancer Res. 2022 06 06; 82(11):2185-2195.
Score: 0.216
-
Activated T cell-derived exosomal PD-1 attenuates PD-L1-induced immune dysfunction in triple-negative breast cancer. Oncogene. 2021 08; 40(31):4992-5001.
Score: 0.203
-
Targeting Glycosylated PD-1 Induces Potent Antitumor Immunity. Cancer Res. 2020 06 01; 80(11):2298-2310.
Score: 0.185
-
Powering Tumor Metastasis with Recycled Fuel. Cancer Cell. 2016 09 12; 30(3):374-375.
Score: 0.146
-
Galectin-9 blockade synergizes with ATM inhibition to induce potent anti-tumor immunity. Int J Biol Sci. 2023; 19(3):981-993.
Score: 0.056